全球生命科学LIMS市场报告
Advancements in R&D labs, especially in pharmaceutical and
biotechnological laboratories, are likely to stoke the growth of
the market during the forecast period. Growing focus on
improving the efficiency of laboratories is also poised to help
the market gain tremendous momentum over the coming
years. Also, low implementation cost, efficient time
management, and compliance with GDP, GCP, and GMP are
the key factors escalating the demand for LIMS.
Moreover, the rising practice of genome and DNA study and invitro
ADME technologies is working in favor of the market.
Associated advantages such as high precision and elimination
of manual data transcription errors are also anticipated to
provide a fillip to the market. Furthermore, the burgeoning
popularity of cloud-based systems is projected to positively
influence the growth of the overall market.